查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区 PCR 技术市场预测至 2030 年 - 区域分析 - 按技术、产品、应用和最终用户
市场调查报告书
商品编码
1562194

亚太地区 PCR 技术市场预测至 2030 年 - 区域分析 - 按技术、产品、应用和最终用户

Asia Pacific PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 148 Pages | 订单完成后即时交付

价格

亚太地区PCR技术市场预计将从2022年的28.352亿美元成长到2030年的54.656亿美元。

PCR 技术投资和资金供应激增，推动亚太 PCR 技术市场发展

到2023 年，全球政府和联邦机构将认识到定量聚合酶炼式反应(qPCR) 和dPCR 产品在基于基因组的研究中的作用，Mirxes 是RNA 技术的领先创新者，专门从事准确、非侵入性且价格合理的血液检测用于早期疾病检测（特别是癌症）的 miRNA 检测试剂盒在 D 轮融资中筹集了 5000 万美元。该公司的主要产品 GASTROClear 是一种体外诊断测试，使用 PCR 来早期检测胃癌。它已被美国 FDA 指定为突破性设备。这是美国FDA首次对用于胃癌早期诊断的IVD检测、东南亚的分子IVD检测以及全球范围内的血液miRNA检测给予这样的分类。有些公司也加大了研发经费，用于基因合成的增强。 2022年，淡马锡向位于印度的健康科技企业Molbio Diagnostics投资了8,500万美元。 Molbio 设计了针对多种疾病的便携式诊断工具，包括爱滋病毒、登革热、疟疾、肝炎和结核病 (TB)。 2021 年，在 E+ 轮融资中，中国一家生产分子诊断工具的床边护理 (POC) 企业 Ustar 筹集了约 260 万美元。 Ustar将使用筹集的部分资金来提高其旗舰高通量、全自动核酸扩增测试仪器的有效性。剩余资金将用于开发下一代检测平台、增加所提供的检测种类以及大量生产家用聚合酶链反应（PCR）检测套件。

因此，疾病特异性基因组学研究和开发的财政支持不断增加，推动了对 PCR 技术的需求。

亚太地区 PCR 技术市场概况

亚太地区 PCR 技术市场分为中国、日本、印度、韩国、澳洲和亚太地区其他地区。亚太地区的市场成长主要归因于外国直接投资的增加；拥有大量高技能、高效率的劳动力；简化政府政策，进而增加对生技领域的投资。此外，传染病和慢性病病例的增加以及政府和非政府措施推动了亚太地区 PCR 技术市场的成长。预测期内中国PCR技术市场的预期成长归因于对高品质医疗保健产品的需求不断增加、中国生活方式疾病的盛行率不断上升、诊断技术的不断发展、诊断中心和医院数量的激增、以及医院医疗设施的持续现代化。在中国，PCR技术用于植入前遗传学诊断（PGD）、癌症治疗和非侵入性产前检测（NIPT）。根据2023年2月发表的《罕见疾病日：为何中国的罕见疾病负担可能成为创新机会》一文，中国约有2,000万人患有罕见疾病。 dPCR 和 qPCR 等 PCR 技术可用于此类罕见疾病的诊断和治疗（以监测治疗反应）。中国癌症盛行率的上升也促进了 PCR 技术市场的成长。根据全球癌症观察站的资料，2020年中国报告约460万癌症病例。中国PCR技术市场收入及2030年预测（百万美元） 从价值来看，2022年中国PCR技术市场价值为7,7623万美元，预计2030年将达到15,4521万美元；预计在预测期内复合年增长率为 9.00%。

亚太地区 PCR 技术市场营收及 2030 年预测（百万美元）

亚太地区 PCR 技术市场区隔

亚太地区 PCR 技术市场分为技术、产品、应用、最终用户和国家。

根据技术，亚太地区PCR技术市场分为即时PCR、常规PCR、逆转录、数位PCR、多重RTPCR、热启动PCR等。 2022 年，即时 PCR 领域在亚太 PCR 技术市场中占据最大份额。

在产品方面，亚太地区 PCR 技术市场分为试剂和耗材、仪器以及软体和服务。到2022年，试剂和耗材细分市场在亚太地区PCR技术市场中占据最大份额。此外，西林瓶尺寸分为0.2ml至2ml、0.1ml至0.3ml、2ml至5ml等西林瓶。此外，仪器部分分为桌上型 PCR 和便携式热循环仪/PCR。

依应用划分，亚太地区 PCR 技术市场细分为基因表现分析、基因定序、基因分型、核酸合成、标准验证、护理诊断应用、环境应用等。 2022 年，基因表现分析领域占据亚太 PCR 技术市场的最大份额。

根据最终用户，亚太地区 PCR 技术市场分为医院和诊断中心、製药和生物技术公司、学术机构和研究实验室等。 2022 年，医院和诊断中心细分市场占据亚太 PCR 技术市场的最大份额。

依国家划分，亚太地区 PCR 技术市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022 年，中国将主导亚太 PCR 技术市场。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Takara Bio Inc、Standard Bio Tools Inc、Agilent Technologies Inc 和 Ellume Ltd 等亚太PCR 技术市场的领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太 PCR 技术市场 - 主要产业动态

  • PCR 技术市场 - 主要产业动态
  • 市场驱动因素
    • 遗传性疾病和传染病的盛行率不断上升
    • PCR 技术的投资和资金供应激增
  • 市场限制
    • PCR 系统的高成本和替代检测的可用性
  • 市场机会
    • 新兴国家越来越多地采用 PCR 技术
    • POC 测试需求不断增加
  • 未来趋势
    • PCR 技术的进步
  • 驱动因素和限制的影响：

第 5 章：PCR 技术市场 - 亚太市场分析

  • PCR 技术市场收入，2020 - 2030

第 6 章：亚太地区 PCR 技术市场分析 - 依技术

  • 概述
  • 实时萤光定量PCR
  • 常规PCR
  • 逆转录聚合酶连锁反应
  • 数位PCR
  • 多重逆转录聚合酶连锁反应
  • 热启动PCR
  • 其他的

第 7 章：亚太地区 PCR 技术市场分析 - 按产品

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额（按产品划分）（%）
  • 试剂及耗材
  • 仪器仪表
  • 软体和服务

第 8 章：亚太地区 PCR 技术市场分析 - 按应用

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额，按应用划分 (%)
  • 基因表现分析
  • 基因定序
  • 基因分型
  • 核酸合成
  • 标准验证
  • 护理点诊断
  • 环境应用
  • 其他的

第 9 章：亚太地区 PCR 技术市场分析 - 按最终用户

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额（按最终用户划分）（%）
  • 医院和诊断中心
  • 学术界及研究机构
  • 製药和生物技术公司
  • 其他的

第 10 章：亚太地区 PCR 技术市场 - 国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 11 章：PCR 技术市场-产业格局

  • 概述
  • PCR 技术市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Takara Bio Inc
  • Standard Biotools Inc
  • Agilent Technologies Inc
  • Ellume Ltd

第 13 章：附录

Product Code: BMIRE00030379

The Asia Pacific PCR technologies market is expected to grow from US$ 2,835.20 million in 2022 to US$ 5,465.60 million by 2030. It is estimated to record a CAGR of 8.6% from 2022 to 2030.

Surging Investments and Funds Availability for PCR Technologies Boost Asia Pacific PCR Technologies Market

Government and federal agencies worldwide recognize the role of quantitative polymerase chain reaction (qPCR) and dPCR products in genome-based research in 2023, Mirxes, a leading innovator in RNA technology, specializes in accurate, non-invasive, and reasonably priced blood-based miRNA testing kits for early disease detection, particularly cancer, raised US $50 million in a Series D funding round. The company's main offering, GASTROClear, is an in vitro diagnostic test that uses PCR to detect stomach cancer early on. It has been designated as a Breakthrough Device by the US FDA. This is the first time that the US FDA has given such a classification to an IVD test for early diagnosis of stomach cancer, a molecular IVD test from Southeast Asia, and a blood miRNA test worldwide. Some companies have also increased their research and development funds for the enhancement of gene synthesis. In In 2022, Temasek contributed US $85 million to the healthtech business Molbio Diagnostics, located in India. Molbio designs portable diagnostic tools for a range of conditions, including HIV, dengue, malaria, hepatitis, and tuberculosis (TB). In 2021, in a Series E+ fundraising round, Ustar, a Chinese point-of-care (POC) business that creates molecular diagnostic tools, raised roughly US$ 2.6 million. Ustar will use a portion of the funds raised to improve the effectiveness of their flagship high-throughput, completely automated nucleic acid amplification test instrument. The remaining funds will go into developing a next generation testing platform, increasing the variety of tests offered, and mass-producing polymerase chain reaction (PCR) testing kits for home usage.

Therefore, the increasing availability of financial support for research and development in disease-specific genomics propels the demand for PCR technologies.

Asia Pacific PCR Technologies Market Overview

The Asia Pacific PCR technologies market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in Asia Pacific is mainly attributed to the increasing foreign direct investments; the large availability of highly skilled, efficient workforces; and streamlining government policies resulting in high investments in the biotechnology sector. In addition, increasing cases of infectious and chronic diseases, and government and non-government initiatives fuel the growth of the PCR technologies market in Asia Pacific. The projected growth of the PCR technologies market in China during the forecast period is attributed to the increasing demand for high-quality healthcare products, growing prevalence of lifestyle diseases in the country, rising developments in diagnostics technologies, surging number of diagnostic centers and hospitals, and the ongoing modernization of medical facilities in hospitals. In China, PCR techniques are used for preimplantation genetic diagnosis (PGD), cancer treatment, and noninvasive prenatal testing (NIPT). According to the article "Rare Disease Day: why China's Rare Disease Burden Could Be an Opportunity for Innovation," published in February 2023, ~20 million Chinese people suffer from rare diseases. PCR techniques such as dPCR and qPCR can be used in the diagnosis and treatment (to monitor treatment response) of such rare conditions. The rising prevalence of cancer in China also contributes to the PCR technologies market growth. According to the Global Cancer Observatory data, ~4.6 million cancer cases were reported in the country in 2020. In addition, cancer resulted in the death of 3.1 million people in China. China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) In terms of value, the PCR technologies market in China was valued at US$ 776.23 million in 2022 and is projected to reach US$ 1,545.21 million by 2030; it is expected to register a CAGR of 9.00% during the forecast period.

Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific PCR Technologies Market Segmentation

The Asia Pacific PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Asia Pacific PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held largest share of Asia Pacific PCR technologies market in 2022.

In terms of offerings, the Asia Pacific PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Asia Pacific PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Asia Pacific PCR technologies market is segmented gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Asia Pacific PCR technologies market in 2022.

Based on end user, the Asia Pacific PCR technologies market is segmented hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held the largest share of Asia Pacific PCR technologies market in 2022.

By country, the Asia Pacific PCR technologies market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Asia Pacific PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
    • 4.4.2 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Asia Pacific Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Asia Pacific PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific PCR Technologies Market -Country Analysis

  • 10.1 Asia Pacific: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
      • 10.1.2.2 China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 China PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 China PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 China PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 China PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 China PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 China PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 China PCR Technologies Market Breakdown by End User
      • 10.1.2.3 Japan
        • 10.1.2.3.1 Overview
      • 10.1.2.4 Japan PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 Japan PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 Japan PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 Japan PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 Japan PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 Japan PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 Japan PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 Japan PCR Technologies Market Breakdown by End User
      • 10.1.2.5 India
        • 10.1.2.5.1 Overview
      • 10.1.2.6 India PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.1 India PCR Technologies Market Breakdown by Technology
        • 10.1.2.6.2 India PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.2.1 India PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.2.2 India PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.2.2.1 India PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.3 India PCR Technologies Market Breakdown by Application
        • 10.1.2.6.4 India PCR Technologies Market Breakdown by End User
      • 10.1.2.7 Australia
        • 10.1.2.7.1 Overview
      • 10.1.2.8 Australia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.1 Australia PCR Technologies Market Breakdown by Technology
        • 10.1.2.8.2 Australia PCR Technologies Market Breakdown by Offerings
        • 10.1.2.8.2.1 Australia PCR Technologies Market Breakdown by Instruments
        • 10.1.2.8.2.2 Australia PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.8.2.2.1 Australia PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.8.3 Australia PCR Technologies Market Breakdown by Application
        • 10.1.2.8.4 Australia PCR Technologies Market Breakdown by End User
      • 10.1.2.9 South Korea
        • 10.1.2.9.1 Overview
      • 10.1.2.10 South Korea PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.10.1 South Korea PCR Technologies Market Breakdown by Technology
        • 10.1.2.10.2 South Korea PCR Technologies Market Breakdown by Offerings
        • 10.1.2.10.2.1 South Korea PCR Technologies Market Breakdown by Instruments
        • 10.1.2.10.2.2 South Korea PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.10.2.2.1 South Korea PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.10.3 South Korea PCR Technologies Market Breakdown by Application
        • 10.1.2.10.4 South Korea PCR Technologies Market Breakdown by End User
      • 10.1.2.11 Rest of Asia Pacific
        • 10.1.2.11.1 Overview
      • 10.1.2.12 Rest of Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.12.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Technology
        • 10.1.2.12.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Offerings
        • 10.1.2.12.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Instruments
        • 10.1.2.12.2.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.12.2.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.12.3 Rest of Asia Pacific PCR Technologies Market Breakdown by Application
        • 10.1.2.12.4 Rest of Asia Pacific PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Takara Bio Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Standard Biotools Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Agilent Technologies Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Ellume Ltd
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030 (US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 31. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 32. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 33. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 34. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 35. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 36. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 37. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 38. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 39. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 40. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 41. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 42. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 43. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 44. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 45. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 46. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 47. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 48. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 49. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 50. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 53. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. Asia Pacific: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Asia Pacific PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 36. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 37. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 38. Growth Strategies in the PCR Technologies Market